{"doi":"10.1097/der.0b013e31826e45d7","title":"Trichomegaly of the Eyelashes During Therapy With Epidermal Growth Factor Receptor Inhibitors: Report of 3 Cases","abstract":"<jats:p>\n                    A wide spectrum of skin toxicities has been described in patients receiving epidermal growth factor receptor (EGFR), inhibitors, including papulopustular rash, xerosis and fissures, pruritus, mucositis, paronychia, and hair\n                    <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"http://changes.Trichomegaly\">changes.Trichomegaly</jats:ext-link>\n                    of the eyelashes is a rare adverse effect of EGFR inhibitor therapy and is characterized by a paradoxical overgrowth of eyelashes. We present 3 cases of trichomegaly occurred during EGFR inhibitor therapy.\n                  </jats:p>","journal":"Dermatitis®","year":2012,"id":682864,"datarank":0.4887144807032224,"base_score":3.258096538021482,"endowment":3.258096538021482,"self_citation_contribution":0.4887144807032224,"citation_network_contribution":0.0,"self_endowment_contribution":0.4887144807032224,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":25,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1783876,"name":"Luigia Panariello","orcid":null,"position":1,"is_corresponding":false},{"id":1783877,"name":"Sara Cacciapuoti","orcid":null,"position":2,"is_corresponding":false},{"id":1783878,"name":"Dario Bianca","orcid":null,"position":3,"is_corresponding":false},{"id":1783879,"name":"Fabio Ayala","orcid":null,"position":4,"is_corresponding":false},{"id":906045,"name":"Gabriella Fabbrocini","orcid":"0000-0002-0064-1874","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Trichomegaly of the Eyelashes During Therapy With Epidermal Growth Factor Receptor Inhibitors: Report of 3 Cases","abstract":"<jats:p>\n                    A wide spectrum of skin toxicities has been described in patients receiving epidermal growth factor receptor (EGFR), inhibitors, including papulopustular rash, xerosis and fissures, pruritus, mucositis, paronychia, and hair\n                    <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"http://changes.Trichomegaly\">changes.Trichomegaly</jats:ext-link>\n                    of the eyelashes is a rare adverse effect of EGFR inhibitor therapy and is characterized by a paradoxical overgrowth of eyelashes. We present 3 cases of trichomegaly occurred during EGFR inhibitor therapy.\n                  </jats:p>","is_dataset_classified":null,"base_score":3.258096538021482,"endowment":3.258096538021482,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23010833","pmcid":null,"openalex_id":"https://openalex.org/W2317657428","authors":[],"funders":[],"total_grants":0,"fwci":1.6429,"citation_percentile":0.84476605,"influential_citations":0,"citation_trend":[{"year":2013,"count":2},{"year":2014,"count":6},{"year":2015,"count":4},{"year":2016,"count":2},{"year":2017,"count":1},{"year":2018,"count":1},{"year":2020,"count":2},{"year":2021,"count":3},{"year":2022,"count":1},{"year":2023,"count":1},{"year":2024,"count":1},{"year":2025,"count":1}],"oa_status":"closed","license":"https://journals.sagepub.com/page/policies/text-and-data-mining-license","oa_locations":[{"url":"https://journals.sagepub.com/doi/pdf/10.1097/DER.0b013e31826e45d7","host_type":"publisher"},{"url":"https://journals.sagepub.com/doi/full-xml/10.1097/DER.0b013e31826e45d7","host_type":"publisher"},{"url":"https://doi.org/10.1097/der.0b013e31826e45d7","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/23010833","host_type":"repository"}],"fields_of_study":["Colorectal Cancer Treatments and Studies","Chemotherapy-related skin toxicity","Colorectal and Anal Carcinomas"],"mesh_terms":["Erlotinib Hydrochloride","Panitumumab","Antibodies, Monoclonal","Antineoplastic Agents","Drug Eruptions","Exanthema","Eyelashes","Female","Hair Diseases","Humans","Middle Aged","Quinazolines","ErbB Receptors"],"keywords":["Medicine","Paronychia","Papulopustular","Dermatology","Mucositis","Epidermal growth factor receptor","Rash","Adverse effect","EGFR inhibitors","Pharmacology","Chemotherapy","Internal medicine","Receptor","Acne"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-17T21:33:57.710421Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}